Selected

Maia AT#, Antoniou AC, O’Reilly M, Samarajiwa S, Dunning M, Kartsonaki C, Chin SF, Curtis CN, McGuffog L, Domchek SM, EMBRACE, Easton DF, Peock S, Frost D, Evans DG, Eeles R, Izatt L, Adlard J, Eccles D, GEMO Study Collaborators, Sinilnikova OM, Mazoyer S, Stoppa-Lyonnet D, Gauthier-Villars M, Faivre L, Venat-Bouvet L, Delnatte C, Nevanlinna H, Couch FJ, Godwin AK, Caligo MA, SWE-BRCA, Barkardottir RB, kConFab Investigators, Chen X, Beesley J, Healey S, Caldas C, Chenevix-Trench G and Ponder BAJ. Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers.
Breast Cancer Research. 2012 Apr 18;14(2):R63
#co-corresponding author;
PubMed | PDF

Maia AT#, Spiteri I, Lee AJX, Jones L, O’Reilly M, Caldas C and Ponder BAJ. Extent of differential allelic expression of candidate breast cancer genes is similar in blood and breast.
Breast Cancer Research, 2009 Dec; 11(6):R88 Epub
#co-corresponding author;
PubMed | PDF

Meyer KB*, Maia AT*, O’Reilly M, Teschendorff AE, Chin SF, Caldas C, Ponder BAJ. Predisposition to breast cancer due to overexpression of FGFR2.
PLoS Biology, 2008 May 6; 6 (5) pp. e108
*co-first authors
PubMed | PDF
See News&Views Nature Genetics

Udler M*, Maia AT*, Cebrian A, Shah M, Caldas C, Dunning A, Ponder B, Easton D, Pharoah P. Common variation in anti-oxidant defense genes and survival after diagnosis of breast cancer.
Journal of Clinical Oncology, 2007 Jul 20;25(21):3015-23
*co-first authors
PubMed | PDF

2012-present

Maia AT, Sammut SF, Jacinta-Fernandes A, Chin SF. Big Data in Cancer Genomics.
Current Opinion in Systems Biology. 2017 Jul 24. Review.
doi: 10.1016/j.coisb.2017.07.007

Faleiro I, Leão R, Binnie A, Andrade de Mello R, Maia AT, Castelo-Branco P. Epigenetic therapy in urologic cancers: an update on clinical trials.
Oncotarget. 2016 Dec 26. Review.
doi: 10.18632/oncotarget.14226
PMID: 28036257

Vollan HK, Rueda OM, Chin SF, Curtis C, Turashvili G, Shah S, Lingjærde OC, Yuan Y, Ng CK, Dunning MJ, Dicks E, Provenzano E, Sammut S, McKinney S, Ellis IO, Pinder S, Purushotham A, Murphy LC, Kristensen VN; METABRIC Group, et al.
Mol Oncol. 2015 Jan;9(1):115-27.
doi: 10.1016/j.molonc.2014.07.019.
PMID: 25169931

Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Cancer Epidemiology, Biomarkers & Prevention. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):308-16.
doi: 10.1158/1055-9965.
PMID: 25336561.

Jones JO, Chin SF, Wang-Taylor LA, Leaford D, Ponder BAJ, Caldas C, Maia AT#, TOX3 somatic mutations in breast cancer.
PLoS One. 2013 Sep 19;8(9):e74102
#co-corresponding author

French JD#, Ghoussaini M#, Edwards S#, Meyer KB#, Michailidou K, Ahmed S, Khan S, Maranian MJ, O’Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, Tyrer J, Maia AT, et al. Fine scale mapping and functional analysis of the breast cancer 11q13 (CCND1) locus.
American Journal of Human Genetics, 2013 Apr 4;92(4):489-503 4.

Liu R, Maia AT, Russell R, Caldas C, Ponder BA, Ritchie ME. Allele-specific expression analysis methods for high-density SNP microarray data.
Bioinformatics. 2012 Apr 15;28(8):1102-8

Curtis C#, Shah SP#, Chin SF#, Turashvili G#, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Gräf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, METABRIC Group, Langerød A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Børresen-Dale AL, Brenton JD, Tavaré S, Caldas C†, Aparicio S†. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.
Nature. 2012 Apr 18;486(7403):346-52

2004-2011

Meyer KB, Maia AT, O’Reilly M, Ghoussaini M, Prathalingam R, Porter-Gill P, Ambs S, Prokunina-Olsson L, Carroll J, Ponder BAJ. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
PLoS Genetics, 21 July 2011, 7(7): e1002165

Azzato EM, Lee AX, Teschendorff A, Ponder BAJ, Pharoah P, Caldas C, Maia AT#. Common germline variation of C1qA in relation to breast cancer risk and survival.
British Journal of Cancer. 2010 Apr 13;102(8):1294-1299
#co-corresponding author

Udler MS, Healey CS, Meyer K, Ahmed S, Struewing J, Maranian M, Kwon EM, Zhang J, Tyrer J, Karlins E, Platte R, Kalmerzyaev B, Dicks E, Field H, Maia AT, Prathalingam R, Teschendorff A, McArthur S, Doody DR, Luben R, Caldas C, Bernstein L, Kolonel LK, Henderson BE, Wu A, Le Marchand L, Ursin G, Press MF, Lindblom A, Shen CY, Wu PE, Wang HC, Kang D, Yoo KY, Noh DY, Ahn SH, Malone KE, Haiman CA, Pharoah PD, Ponder BAJ, Ostrander E, Easton DF and Dunning AM. Towards identifying the function of the breast cancer 16q12 locus.
Human Molecular Genetics. 2010 Jun 15;19(12):2507-2515

Alves M, Carreira I, Liberato P, Ramos S, Mafra M, Inverno AS, Maia AT, Martins AP, Brito M, Monteiro C. Identification of a 0.4 Kb deletion region in 10q26 associated with endometrial carcinoma.
Oncology Reports 2010 Feb; 23(2):519-522

Dunning AM, Healey CS, Baynes C, Maia AT, Scollen S, Vega A, et al. Association of ESR1 gene tagging SNPs with breast cancer risk.
Human Molecular Genetics 2009 Mar 15; 18(6): 1131-1139

Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N, Dwerryhouse S, Lao-Sirieix P, Caldas C and Fitzgerald RC. Mechanisms and sequelae of E-cadherin silencing in Hereditary Diffuse Gastric Cancer.
The Journal of Pathology 2008 Nov; 216 (3):295-306

Ito Y, Kossler T, Ibrahim A, Ibrahim AEK, Rai S, Vowler SL, Abu-Amero S, Silva AL, Maia AT, Huddleston J, Uribe-Lewis S, Woodfine K, Jagodic M, Nativio R, Dunning A, Moore G, Klenova E, Bingham S, Pharoah P, Brenton J, Beck S, Sandhu MS, Murrell.A. Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer.
Human Molecular Genetics, 2008 Sep 1;17(17): 2633-2643

Bundy JG, Iyer NG, Gentile MS, Hu DE, Kettunen M, Maia AT, Thorne NP, Brenton JD, Caldas C, Brindle KM. Metabolic consequences of p300 gene deletion in human colon cancer cells.
Cancer Research. 2006 Aug 1;66(15):7606-7614

2001-2003

Maia AT*, Tussiwand R*, Cazzaniga G, Rebulla P, Colman S, Biondi A, Greaves M. Identification of pre-leukaemic precursors of hyperdiploid acute lymphoblastic leukaemia in cord blood.
Genes Chromosomes and Cancer. 2004 May;40(1):38-43
*co-first authors

Maia AT, Koechling J, Corbett R, Metzler M, Wiemels J, Greaves M. Duration of post-natal latency in childhood leukaemia.
Genes Chromosomes and Cancer. 2004 Apr;39(4):335-340

Zuna J, Muzikova K, Ford AM, Maia AT, Krejci O, Tousovska K, Oravkinova I, Greaves M, Trka J. Pre-Natal Clonal Origin of Acute Lymphoblastic Leukaemia in Triplets
Leukemia and Lymphoma 2003 December; 44(12):2099-2102

Maia AT#, van der Velden VHJ, Harrison CJ, Szczepanski T, Williams MD, Griffiths M, van Dongen JJM, Greaves M. Pre-natal origin of hyperdiploid acute lymphoblastic leukemia in identical twins
Leukemia 2003 Nov; 17(11):2202-2206
#co-corresponding author

Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in Twins: Lessons in Natural History. Review
Blood. 2003 Oct 1;102(7):2321-2333

Wiemels JL, Xiao Z, Buffler PA, Maia AT, Ma X, Dicks BM, Smith MT, Zhang L, Feusner J, Wiencke J, Pritchard-Jones K, Kempski H, Greaves M. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia.
Blood. 2002 May 15; 99(10):3801-3805

Maia AT, Ford AM, Jalali GR, Harrison CJ, Taylor GM, Eden OB, Greaves MF. Molecular tracking of leukemogenesis in a triplet pregnancy.
Blood. 2001 Jul 15; 98(2):478-482